Concepedia

Claudia Sala

CS

64

Publications

8.9K

Citations

32

H-Index

2001

Active since

Affiliations

École Polytechnique Fédérale de Lausanne(Current)

Toscana Life Sciences

University of Siena

Univesity of Life Science "King Mihai I" from Timisoara

VisMederi Research

Claudia Sala is an author at École Polytechnique Fédérale de Lausanne specializing in medicine, microbiology, and tuberculosis.

Top concepts

MedicineMicrobiologyTuberculosisClinical MicrobiologyAntimicrobial ResistanceMolecular BiologyImmunologyGene ExpressionNatural SciencesDrug Resistance

Publications per year

2001–2024

64

Publications

64

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2020 · 5K citations · Full text

Benzothiazinones Kill <i>Mycobacterium tuberculosis</i> by Blocking Arabinan Synthesis

Vadim Makarov, Giulia Manina, Katarı́na Mikus̃ová et al. · Science · 2009 · 722 citations · Full text

Bioorganic Chemistry, Major Btz Target, Antimicrobial Chemotherapy +18

Extremely potent human monoclonal antibodies from COVID-19 convalescent patients

Emanuele Andreano, Emanuele Nicastri, Ida Paciello et al. · Cell · 2021 · 237 citations · Full text

Immunology, Antibody Screening, Antibody Engineering +4

Towards a new tuberculosis drug: pyridomycin – nature's isoniazid

Ruben C. Hartkoorn, Claudia Sala, João Neres et al. · EMBO Molecular Medicine · 2012 · 184 citations · Full text

Lansoprazole is an antituberculous prodrug targeting cytochrome bc1

Jan Rybniker, Anthony Vocat, Claudia Sala et al. · Nature Communications · 2015 · 180 citations · Full text

Rows per page

1–5 of 64